Carbamazepine protects against megencephaly and abnormal expression of BDNF and Nogo signaling components in the mceph/mceph mouse
Carbamazepine (CBZ) is a commonly used antiepileptic drug known to block voltage-gated sodium channels. Infants exposed to CBZ in utero show reduced head circumference, for reasons unknown. We investigated CBZ's effect on neural growth in megencephaly (mceph/mceph) mice lacking functional Kv1.1...
Main Authors: | Catharina Lavebratt, Alexandra Trifunovski, Ann-Sophie Persson, Fu-Hua Wang, Tomas Klason, Inger Öhman, Anna Josephsson, Lars Olson, Christian Spenger, Martin Schalling |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-11-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996106001756 |
Similar Items
-
Carbamazepine protects against neuronal hyperplasia and abnormal gene expression in the megencephaly mouse
by: Malin Almgren, et al.
Published: (2008-12-01) -
Carbamazepine treatment recovered low N-acetylaspartate+N-acetylaspartylglutamate (tNAA) levels in the megencephaly mouse BALB/cByJ-Kv1.1mceph/mceph
by: Eric Westman, et al.
Published: (2007-04-01) -
Evidence for presence and functional effects of Kv1.1 channels in β-cells: general survey and results from mceph/mceph mice.
by: Zuheng Ma, et al.
Published: (2011-04-01) -
Cystic Leukoencephalopathy with Normocephaly
by: J Gordon Millichap
Published: (2005-05-01) -
A truncated Kv1.1 protein in the brain of the <it>megencephaly </it>mouse: expression and interaction
by: Århem Peter, et al.
Published: (2005-11-01)